Related Experiment Video
Updated: Jan 19, 2026
06:08
Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
11.1K
Job satisfaction, work commitment and intention to leave among pharmacists: a cross-sectional study
Nedaa Al-Muallem1, Khaled Mohammed Al-Surimi2,3,4
1Department of Health System Management, College of Public Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
BMJ Open
|September 28, 2019
Summary
Pharmacists in Saudi Arabia report job satisfaction and commitment but still intend to leave their roles. Further research is needed to understand the drivers behind this intention to leave pharmacy practice.
Area of Science:
- Pharmacy Practice
- Healthcare Workforce Studies
- Occupational Health Psychology
Background:
- Understanding job satisfaction, work commitment, and intention to leave is crucial for retaining healthcare professionals.
- Pharmacists play a vital role in Saudi Arabia's healthcare system, making workforce stability a key concern.
Purpose of the Study:
- To assess job satisfaction, work commitment, and intention to leave among pharmacists in Saudi Arabia.
- To identify factors influencing pharmacists' decisions to leave their current practice settings.
Main Methods:
- A cross-sectional study was conducted using a validated questionnaire.
- 325 pharmacists from various healthcare settings in Riyadh, Saudi Arabia, participated.
- Data were analyzed using multiple logistic regression.
Main Results:
- Most pharmacists were satisfied with their jobs (63.7%) and committed to their work.
- A significant proportion (61.9%) expressed an intention to leave their current positions.
- Job satisfaction and work commitment were significant predictors of intention to leave, while demographics were not.
Conclusions:
- Despite job satisfaction and commitment, a considerable number of pharmacists intend to leave their jobs in Saudi Arabia.
- Further investigation is recommended to elucidate the specific reasons for this intention to leave.
- Addressing the identified predictors may help improve pharmacist retention in Saudi Arabia.
More Related Videos
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
190
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
190
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:12Analysis of Population Pharmacokinetic Data
682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
192
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
192
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
217
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
217
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155